GO:0006368 transcription elongation by RNA polymerase II: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006368 describes the extension of an RNA molecule after promoter clearance by RNA polymerase II (Pol II), a central step in gene expression.
• Elongation is not a passive process; it is tightly regulated by factors such as P-TEFb, SPT5, and the INTAC complex.
• The rate of Pol II elongation directly influences co-transcriptional processes like alternative splicing.
• Plant studies reveal conserved and plant-specific elongation factors that modulate transcription in response to environmental cues.
• Dysregulation of elongation is linked to cancer and developmental disorders, making it a therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in) are essential to dissect the causal roles of elongation factors.
Description
Transcription elongation by RNA polymerase II (GO:0006368) is the phase of gene expression in which Pol II synthesizes the nascent RNA transcript after escaping the promoter. This process is highly regulated and coupled to RNA processing, chromatin modification, and cellular signaling. Understanding elongation is critical because its kinetics and fidelity impact transcript diversity, gene expression levels, and cellular responses to stress. Research over the past decades has identified numerous elongation factors, such as P-TEFb, SPT5, and the INTAC complex, that control Pol II pausing, processivity, and termination. These factors are conserved across eukaryotes, including plants, where they fine-tune gene expression for development and environmental adaptation. Given its central role, elongation is a focal point for studies on cancer, viral infection, and neurodevelopmental disorders. This article synthesizes current knowledge on the mechanisms, key genes, and research methods for studying GO:0006368, providing a resource for researchers aiming to manipulate or measure this process.
transcription elongation by RNA polymerase II At A Glance
| GO ID | GO:0006368 |
|---|---|
| GO term | transcription elongation by RNA polymerase II |
| Ontology | biological_process |
| Synonym | RNA elongation from Pol II promoter; RNA polymerase II transcription elongation factor activity; transcription elongation by RNA polymerase II promoter; transcription elongation from RNA polymerase II promoter |
| Major function | Synthesis of RNA transcript by RNA polymerase II after promoter clearance |
| Related cellular component | RNA polymerase II complex, elongation factors |
| Related molecular function | RNA polymerase II activity, transcription elongation factor activity |
| Pathway context | Gene expression, transcription |
What Is GO:0006368?
GO:0006368, transcription elongation by RNA polymerase II, is defined as the extension of an RNA molecule after transcription pausing and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II. In simpler terms, it is the stage where the polymerase moves along the DNA template, adding nucleotides to the growing RNA chain, following the initial pause and escape from the promoter.
Why Is transcription elongation by RNA polymerase II Important in Cell Biology?
Transcription elongation by RNA polymerase II is a critical regulatory hub that determines the output and fidelity of gene expression. It is not merely a constitutive step; elongation rates and pausing influence alternative splicing, RNA processing, and chromatin states. Dysregulation of elongation factors is implicated in cancer, where oncogenes such as MYC and MCL1 depend on P-TEFb activity. Moreover, elongation is a target for therapeutic intervention, as inhibiting kinases like CDK9 can selectively downregulate short-lived transcripts. In plants, elongation factors modulate responses to environmental stress and developmental transitions. Thus, understanding GO:0006368 is essential for basic biology and translational research.
• Elongation controls the rate of RNA synthesis, affecting gene expression levels.
• It is coupled to co-transcriptional splicing, influencing transcript diversity.
• P-TEFb (CDK9/cyclin T) is a master regulator of elongation and a drug target in cancer.
• SPT5 stabilizes Pol II and maintains enhancer landscapes.
• The INTAC complex integrates phosphatase and endonuclease activities to regulate elongation and termination.
• Plant elongation factors are crucial for development and stress responses.
• Dysregulation of elongation is linked to leukemia and other malignancies.
• Elongation rates can be measured genome-wide to study gene regulation.
• Termination is coupled to elongation and involves DNA-directed mechanisms.
• CRISPR screens can identify novel elongation regulators.
What Happens During transcription elongation by RNA polymerase II?
Promoter Escape and Pausing
In simple terms: After starting transcription, Pol II pauses near the promoter and needs a signal to continue.
Following transcription initiation, RNA polymerase II (Pol II) often pauses at promoter-proximal regions. This pause is stabilized by factors such as DSIF (SPT4/SPT5) and NELF. The pause serves as a checkpoint for regulatory inputs. Release from pausing requires the kinase P-TEFb, which phosphorylates SPT5 and the Pol II C-terminal domain (CTD), allowing elongation to proceed. SPT5 plays a key role in stabilizing Pol II and orchestrating transcription cycles.
Processive Elongation
In simple terms: The polymerase moves along the DNA, adding nucleotides to the RNA chain.
Once released, Pol II synthesizes RNA processively, adding ribonucleotides complementary to the DNA template. Elongation rates vary across genes and can be modulated by elongation factors. The INTAC complex, which contains the phosphatase PP2A and the endonuclease INTS11, regulates Pol II elongation by dephosphorylating the CTD and cleaving nascent RNA. This fine-tunes elongation and facilitates termination.
Coupling with RNA Processing
In simple terms: While making RNA, the polymerase also coordinates with machinery that processes the RNA.
Elongation is physically and functionally coupled to RNA processing events such as capping, splicing, and polyadenylation. The rate of elongation can influence alternative splicing decisions, as slower elongation allows more time for splice site selection. This coupling ensures that transcripts are correctly processed before export.
Termination and Recycling
In simple terms: At the end of the gene, the polymerase stops and is recycled.
Termination of Pol II transcription involves both polyadenylation-dependent and DNA-directed mechanisms. Recent studies have shown that DNA sequences can direct termination, and factors like the INTAC complex participate in this process. Proper termination is essential for preventing read-through transcription and maintaining gene boundaries.
Key Genes Involved in GO:0006368 transcription elongation by RNA polymerase II
The following genes and proteins are central to transcription elongation by RNA polymerase II, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR2A | Largest subunit of RNA polymerase II | Core catalytic subunit; target for inhibitors |
| CDK9 | Kinase subunit of P-TEFb | Phosphorylates SPT5 and Pol II CTD to release pausing |
| CCNT1 | Cyclin T1, regulatory subunit of P-TEFb | Partners with CDK9; regulates elongation |
| SUPT5H | SPT5, elongation factor | Stabilizes Pol II, maintains enhancer landscape |
| SUPT4H1 | SPT4, partner of SPT5 | Forms DSIF complex with SPT5 |
| NELFA | NELF subunit A | Negative elongation factor; stabilizes paused Pol II |
| INTS11 | Integrator subunit 11, endonuclease | RNA cleavage and termination |
| PPP2CA | Catalytic subunit of PP2A | Dephosphorylates Pol II CTD; part of INTAC |
| ELL2 | Elongation factor | Stimulates Pol II elongation |
| AFF4 | Scaffold protein of SEC | Part of super elongation complex |
| MLLT3 | ENL/AF9, part of SEC | Links elongation to chromatin |
| BRD4 | Bromodomain protein | Recruits P-TEFb to chromatin |
| CTDP1 | FCP1 phosphatase | Dephosphorylates Pol II CTD |
| SUPT6H | SPT6, elongation factor | Couples elongation with chromatin |
| ELF1 | Elongation factor | Promotes elongation in plants |
| ELP1 | Elongator subunit | Modifies tRNA and regulates elongation |
| SPT16 | FACT subunit | Reorganizes nucleosomes during elongation |
How Is transcription elongation by RNA polymerase II Regulated?
Transcription elongation by RNA polymerase II is regulated at multiple levels. The most prominent is phosphorylation of the Pol II CTD and SPT5 by P-TEFb (CDK9/cyclin T), which is recruited by BRD4 and other factors. The INTAC complex counteracts this by dephosphorylating the CTD via PP2A and cleaving nascent RNA via INTS11. Additionally, elongation is influenced by chromatin structure, with factors like SPT6 and FACT modulating nucleosome stability. In plants, elongation factors such as ELF1 and ELP1 are regulated by developmental and environmental signals. Furthermore, elongation rates can be modulated by cellular stress and signaling pathways, though specific mechanisms remain to be fully elucidated.
transcription elongation by RNA polymerase II and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDK9 | Leukemia, lymphoma | Knockout or point mutation in cell lines; xenograft models |
| SUPT5H | Neurodevelopmental disorder | Knock-in of patient mutations in iPSCs; knockout in zebrafish |
| INTS11 | Neurodevelopmental syndrome | Knockout in mouse models; patient-derived fibroblasts |
| BRD4 | Cancer (e.g., NUT midline carcinoma) | Overexpression and knockout in cancer cell lines |
| ELP1 | Familial dysautonomia | Point mutation knock-in in mice; iPSC-derived neurons |
Cancer
Dysregulation of transcription elongation is a hallmark of many cancers. P-TEFb is frequently overactivated in hematological malignancies, where it drives expression of oncogenes such as MYC and MCL1. Inhibitors of CDK9, such as dinaciclib, are in clinical trials for leukemia and solid tumors. The INTAC complex has also been implicated in cancer, with mutations in INTS11 found in some tumors.
Neurodevelopmental Disorders
Mutations in elongation factors can cause neurodevelopmental disorders. For example, mutations in SUPT5H (SPT5) are associated with a rare developmental disorder characterized by intellectual disability and dysmorphic features. Similarly, defects in the Integrator complex, which regulates elongation and termination, lead to neurodevelopmental syndromes.
Viral Infection
Many viruses hijack the host elongation machinery to promote their own gene expression. HIV-1, for instance, relies on the viral protein Tat to recruit P-TEFb to the viral promoter, enabling efficient elongation. Targeting P-TEFb is a strategy to block HIV replication.
From transcription elongation by RNA polymerase II-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of CDK9 inhibit elongation? | CRISPR knockout in HEK293T or cancer cell lines |
| What is the effect of a patient mutation in SUPT5H? | Point mutation knock-in in iPSCs followed by neuronal differentiation |
| Can we tag endogenous SPT5 to study its dynamics? | Knock-in of fluorescent tag (e.g., GFP) using CRISPR |
| Does overexpression of INTS11 affect termination? | Overexpression in cell lines followed by RNA-seq |
| What genes are essential for elongation? | Genome-wide CRISPR library screening |
| How does ELF1 regulate plant elongation? | Knockout and overexpression in Arabidopsis |
How to Study the transcription elongation by RNA polymerase II Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 4sU labeling + RNA-seq | Nascent RNA synthesis and elongation rates | Measuring gene-specific elongation rates |
| ChIP-seq for Pol II | Genome-wide distribution of Pol II | Identifying pausing and elongation defects |
| CRISPR knockout screens | Essential genes for elongation | Discovering novel regulators |
| AP-MS | Protein-protein interactions | Characterizing elongation complexes |
| In vitro transcription assays | Kinetics of Pol II elongation | Mechanistic studies with purified components |
| RNA-seq | Steady-state RNA levels | Assessing impact of elongation factor perturbations |
| Bru-seq | Nascent RNA | Mapping transcriptionally active regions |
| Phospho-specific antibodies + Western blot | Phosphorylation status of Pol II CTD | Monitoring P-TEFb activity |
Measuring Elongation Rates
Kinetic measurement of gene-specific Pol II elongation rates can be achieved using techniques such as 4sU labeling followed by RNA-seq or by analyzing nascent RNA with Bru-seq. These methods provide quantitative insights into how fast Pol II transcribes specific genes under different conditions.
Genome-wide Profiling of Pol II
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for Pol II and its phosphorylated forms (e.g., Ser2P, Ser5P) reveals the distribution of elongating polymerase across the genome. This can identify pausing sites and elongation defects.
CRISPR Screens for Elongation Regulators
Pooled CRISPR knockout screens can identify genes required for transcription elongation. For example, a screen targeting kinases and phosphatases identified regulators of Pol II pausing and release. Such screens are powerful for discovering novel elongation factors.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify protein complexes associated with elongation factors, such as the INTAC complex. This approach reveals the composition and dynamics of elongation machinery.
How CRISPR Can Be Used to Study GO:0006368 transcription elongation by RNA polymerase II
Knockout
CRISPR knockout of elongation factor genes (e.g., CDK9, SUPT5H) in cell lines can reveal their essential roles in transcription and cell viability. Knockout models are useful for studying loss-of-function phenotypes and identifying compensatory mechanisms.
Point Mutation
Introducing specific point mutations (e.g., in the kinase domain of CDK9 or in SUPT5H) via CRISPR can mimic patient mutations or inactivate catalytic activity, allowing precise structure-function studies.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into endogenous loci enables live-cell imaging and proteomic analysis of elongation factors. This approach preserves native regulation and stoichiometry.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can be used to study gain-of-function effects of elongation factors, such as INTS11 or ELF1, on transcription and cellular phenotypes.
How EDITGENE Supports transcription elongation by RNA polymerase II Research
Researchers studying transcription elongation by RNA polymerase II-related genes often need to determine whether a candidate gene is causally involved in elongation regulation, and how specific mutations affect Pol II dynamics. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional dissection of elongation factors in health and disease.
Contact EDITGENE today to design your custom CRISPR model for transcription elongation by RNA polymerase II research.
Frequently Asked Questions About transcription elongation by RNA polymerase II
What is transcription elongation by RNA polymerase II?
It is the process by which RNA polymerase II extends the nascent RNA transcript after promoter clearance, as defined by GO:0006368.
What genes are involved in transcription elongation by RNA polymerase II?
Key genes include POLR2A, CDK9, CCNT1, SUPT5H, SUPT4H1, NELFA, INTS11, PPP2CA, ELL2, AFF4, BRD4, and others.
How is transcription elongation regulated?
It is regulated by phosphorylation of Pol II and SPT5 by P-TEFb, and by phosphatases like PP2A in the INTAC complex.
What diseases are associated with defects in transcription elongation?
Cancer, neurodevelopmental disorders, and viral infections are linked to elongation dysregulation.
How can I measure transcription elongation rates?
Techniques such as 4sU labeling followed by RNA-seq or Bru-seq can measure gene-specific elongation rates.
What is the role of P-TEFb in elongation?
P-TEFb (CDK9/cyclin T) phosphorylates SPT5 and Pol II CTD to release paused polymerase and promote elongation.
What is the INTAC complex?
INTAC is a complex containing PP2A and INTS11 that regulates Pol II elongation and termination by dephosphorylation and RNA cleavage.
Can CRISPR be used to study elongation factors?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect elongation factor functions.
What is the difference between transcription initiation and elongation?
Initiation involves promoter recognition and transcription start, while elongation is the subsequent processive RNA synthesis.
How does elongation affect alternative splicing?
Elongation rate can influence splice site selection, coupling transcription with RNA processing.
Conclusion
Transcription elongation by RNA polymerase II (GO:0006368) is a dynamic and highly regulated process essential for gene expression. Advances in CRISPR technology and genomic methods have illuminated the roles of key factors like P-TEFb, SPT5, and INTAC in controlling elongation and its coupling to RNA processing. Dysregulation of elongation contributes to cancer and developmental disorders, making it a promising therapeutic target. Continued research using precise cell models will further unravel the complexities of this process and its impact on human health.
References
- 1. Hu S et al.. 2023. INTAC endonuclease and phosphatase modules differentially regulate transcription by RNA polymerase II.. Mol Cell 83(10):1588-1604.e5 PMID: 37080207
- 2. Giono LE et al.. 2020. Linking transcription, RNA polymerase II elongation and alternative splicing.. Biochem J 477(16):3091-3104 PMID: 32857854
- 3. Hu S et al.. 2021. SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape.. Mol Cell 81(21):4425-4439.e6 PMID: 34534457
- 4. Obermeyer S et al.. 2024. Transcript elongation by RNA polymerase II in plants: factors, regulation and impact on gene expression.. Plant J 118(3):645-656 PMID: 36703573
- 5. Fujinaga K et al.. 2023. P-TEFb: The master regulator of transcription elongation.. Mol Cell 83(3):393-403 PMID: 36599353
- 6. Liu H et al.. 2025. Kinetic measurement of gene-specific RNA polymerase II transcription elongation rates.. Genome Res 35(11):2550-2562 PMID: 41125442
- 7. Obermeyer S et al.. 2023. Different elongation factors distinctly modulate RNA polymerase II transcription in Arabidopsis.. Nucleic Acids Res 51(21):11518-11533 PMID: 37819035
- 8. Han Z et al.. 2023. DNA-directed termination of RNA polymerase II transcription.. Mol Cell 83(18):3253-3267.e7 PMID: 37683646
